Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma. Issue 5 (July 2015)
- Record Type:
- Journal Article
- Title:
- Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma. Issue 5 (July 2015)
- Main Title:
- Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma
- Authors:
- Higashi, Michiyo
Yokoyama, Seiya
Yamamoto, Takafumi
Goto, Yuko
Kitazono, Ikumi
Hiraki, Tsubasa
Taguchi, Hiroki
Hashimoto, Shinichi
Fukukura, Yoshihiko
Koriyama, Chihaya
Mataki, Yuko
Maemura, Kosei
Shinchi, Hiroyuki
Jain, Maneesh
Batra, Surinder K.
Yonezawa, Suguru - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objectives</title> <p>The aim of this study was to further examine the utility of mucin (MUC) expression profiles as prognostic factors in pancreatic ductal adenocarcinoma (PDAC).</p> </sec> <sec> <title>Methods</title> <p>Mucin expression was examined by immunohistochemistry analysis in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from 114 patients with PDAC. The rate of expression of each MUC was compared with clinicopathologic features.</p> </sec> <sec> <title>Results</title> <p>The expression rates of MUCs in cancer lesions were MUC1, 87.7%; MUC2, 0.8%; MUC4, 93.0%; MUC5AC, 78.9%; MUC6, 24.6%; and MUC16, 67.5%. MUC1 and MUC4 were positive, and MUC2 was negative in most PDACs. Patients with advanced stage of PDAC with MUC5AC expression had a significantly better outcome than those who were MUC5AC-negative (<italic>P</italic> = 0.002). With increasing clinical stage, total MUC6 expression decreased (<italic>P</italic> for trend = 0.001) and MUC16 cytoplasmic expression increased (<italic>P</italic> for trend = 0.02). The prognosis of patients with MUC16 cytoplasmic expression was significantly poorer than those without this expression. Multivariate survival analysis revealed that MUC16 cytoplasmic expression was a significant independent predictor of a poor prognosis after adjusting for the effects of other prognostic factors (<italic>P</italic> = 0.002).</p> </sec><abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objectives</title> <p>The aim of this study was to further examine the utility of mucin (MUC) expression profiles as prognostic factors in pancreatic ductal adenocarcinoma (PDAC).</p> </sec> <sec> <title>Methods</title> <p>Mucin expression was examined by immunohistochemistry analysis in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from 114 patients with PDAC. The rate of expression of each MUC was compared with clinicopathologic features.</p> </sec> <sec> <title>Results</title> <p>The expression rates of MUCs in cancer lesions were MUC1, 87.7%; MUC2, 0.8%; MUC4, 93.0%; MUC5AC, 78.9%; MUC6, 24.6%; and MUC16, 67.5%. MUC1 and MUC4 were positive, and MUC2 was negative in most PDACs. Patients with advanced stage of PDAC with MUC5AC expression had a significantly better outcome than those who were MUC5AC-negative (<italic>P</italic> = 0.002). With increasing clinical stage, total MUC6 expression decreased (<italic>P</italic> for trend = 0.001) and MUC16 cytoplasmic expression increased (<italic>P</italic> for trend = 0.02). The prognosis of patients with MUC16 cytoplasmic expression was significantly poorer than those without this expression. Multivariate survival analysis revealed that MUC16 cytoplasmic expression was a significant independent predictor of a poor prognosis after adjusting for the effects of other prognostic factors (<italic>P</italic> = 0.002).</p> </sec> <sec> <title>Conclusions</title> <p>Mucin expression profiles in ultrasound-guided fine-needle aspiration specimens have excellent diagnostic utility and are useful predictors of outcome in patients with PDAC.</p> </sec> </abstract> … (more)
- Is Part Of:
- Pancreas. Volume 44:Issue 5(2015)
- Journal:
- Pancreas
- Issue:
- Volume 44:Issue 5(2015)
- Issue Display:
- Volume 44, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 44
- Issue:
- 5
- Issue Sort Value:
- 2015-0044-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-07
- Subjects:
- Pancreas -- Diseases -- Periodicals
Pancreas -- Periodicals
Neuroendocrine tumors -- Periodicals
616.37005 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00006676-000000000-00000 ↗
http://www.pancreasjournal.com ↗
http://journals.lww.com/pancreasjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPA.0000000000000362 ↗
- Languages:
- English
- ISSNs:
- 0885-3177
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6357.351500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4329.xml